Literature DB >> 6575217

[Changes of therapy results in acute leukemia under different treatment schedules with special reference to gnotobiotic measures].

H Link, H M Frauer, K Wilms, H D Waller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6575217     DOI： 10.1007/bf01485023

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  52 in total

1.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results.

Authors:  M Dietrich; W Gaus; J Vossen; D van der Waaij; F Wendt
Journal:  Infection       Date:  1977       Impact factor: 3.553

2.  Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

Authors:  E D Thomas; C D Buckner; R A Clift; A Fefer; F L Johnson; P E Neiman; G E Sale; J E Sanders; J W Singer; H Shulman; R Storb; P L Weiden
Journal:  N Engl J Med       Date:  1979-09-13       Impact factor: 91.245

Review 3.  Advances in the treatment of acute myelogenous leukemia.

Authors:  R P Gale
Journal:  N Engl J Med       Date:  1979-05-24       Impact factor: 91.245

4.  Improved survival from acute lymphoblastic leukemia in adolescents and adults.

Authors:  H A Blacklock; J R Matthews; J G Buchanan; P A Ockelford; R S Hill
Journal:  Cancer       Date:  1981-11-01       Impact factor: 6.860

5.  Prolonged remissions in adults with acute leukemia following late intensification chemotherapy and immunotherapy.

Authors:  G P Bodey; E J Freireich; K B McCredie; T L Smith; E A Gehan; J U Gutterman; E M Hersh
Journal:  Cancer       Date:  1981-04-15       Impact factor: 6.860

6.  [Therapeutic results in patients with acute leukemia].

Authors:  K Wilms; M Haen; H Rückle; R Maulbetsch; H D Waller
Journal:  Verh Dtsch Ges Inn Med       Date:  1978

7.  [Clinical and cell kinetic data on the combination of cytosine arabinoside with daunorubicin, isosfamide, thioguanine, and vincristine for remission induction and maintenance in patients with acute myelocytic leukaemia (author's transl)].

Authors:  T h Büchner; D Kamanabroo; D Urbanitz; W Hiddemann; J van de Loo
Journal:  Blut       Date:  1978-06-20

8.  High remission-induction rate in acute myeloid leukaemia.

Authors:  R P Gale; M J Cline
Journal:  Lancet       Date:  1977-03-05       Impact factor: 79.321

9.  [Bone marrow transplantation in patients with leukemia].

Authors:  K Wilms; H Link; P Meyer; P Ostendorf; K Schüch; H D Waller; P Wernet; D Niethammer; H Dopfer; W Schneider; F Schunter; G Breitling; W Frommhold; G Seeger; A C Voss
Journal:  Klin Wochenschr       Date:  1982-10-15

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1976-12       Impact factor: 7.640
View more
  2 in total

1.  Therapy for acute myeloid leukemia in 119 adults: a comparison of two treatment protocols.

Authors:  H Link; H M Frauer; P Ostendorf; H D Waller
Journal:  Blut       Date:  1985-07

2.  Bone marrow transplantation for acute leukemia in second or subsequent remission.

Authors:  P Ostendorf; G Ehninger; M L Kallmayer; H Link; K Schüch; K Wilms; C Müller; P Wernet; H Dopfer; D Niethammer
Journal:  Klin Wochenschr       Date:  1984-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.